Cargando…

Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder

IMPORTANCE: The demand for medications for opioid use disorder (MOUD) in rural US counties far outweighs their availability. Novel approaches to extend treatment capacity include telemedicine (TM) and mobile treatment on demand; however, their combined use has not been reported or evaluated. OBJECTI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weintraub, Eric, Seneviratne, Chamindi, Anane, Jessica, Coble, Kelly, Magidson, Jessica, Kattakuzhy, Sarah, Greenblatt, Aaron, Welsh, Christopher, Pappas, Alexander, Ross, Terri L., Belcher, Annabelle M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397932/ https://www.ncbi.nlm.nih.gov/pubmed/34448869 http://dx.doi.org/10.1001/jamanetworkopen.2021.18487

Ejemplares similares

Buprenorphine Induction in a Rural Maryland Detention Center During COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals With Opioid Use Disorder
por: Belcher, Annabelle M., et al.
Publicado: (2021)

Overdue for an Overhaul: How Opioid Treatment Programs Can Learn From COVID-19
por: Greenblatt, Aaron D., et al.
Publicado: (2020)

Patient Satisfaction With Medications for Opioid Use Disorder Treatment via Telemedicine: Brief Literature Review and Development of a New Assessment
por: Cole, Thomas O., et al.
Publicado: (2021)

Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore
por: Abidogun, Tolulope M., et al.
Publicado: (2023)

Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees
por: Hammerslag, Lindsey R., et al.
Publicado: (2023)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder
por: CLIFTON, JOHN M., et al.
Publicado: (2022)

Case Series of Patients with Opioid Use Disorder and Suicidal Ideation Treated with Buprenorphine
por: Spaderna, Max, et al.
Publicado: (2020)

Race-based differences in drug use prior to onset of opioid use disorder
por: Deutsch-Link, Sasha, et al.
Publicado: (2023)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Buprenorphine Dosage and Urine Quantitative Buprenorphine, Norbuprenorphine, and Creatinine Levels in an Office-Based Opioid Treatment Program
por: Furo, Hiroko, et al.
Publicado: (2021)

The pressing shortage of buprenorphine prescribers and the pending role of telemedicine
por: Molfenter, Todd
Publicado: (2015)

Advances in the delivery of buprenorphine for opioid dependence
por: Rosenthal, Richard N, et al.
Publicado: (2017)

Role of Buprenorphine in an Adolescent with Opioid Abuse
por: Weesner, Elizabeth, et al.
Publicado: (2022)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Treating Homeless Opioid Dependent Patients with Buprenorphine in an Office-Based Setting
por: Alford, Daniel P., et al.
Publicado: (2007)

Implementation of emergency department–initiated buprenorphine for opioid use disorder in a rural southern state
por: Bogan, Carolyn, et al.
Publicado: (2020)

Treatment of opioid dependence with buprenorphine: current update
por: Soyka, Michael
Publicado: (2017)

The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
por: De Aquino, Joao P., et al.
Publicado: (2021)

Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine
por: Noble, Florence, et al.
Publicado: (2019)

Serotonin Transporter Genomic Biomarker for Quantitative Assessment of Ondansetron Treatment Response in Alcoholics
por: Seneviratne, Chamindi, et al.
Publicado: (2012)

Advances in Medications and Tailoring Treatment for Alcohol Use Disorder
por: Seneviratne, Chamindi, et al.
Publicado: (2015)

Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period
por: Lembke, Anna, et al.
Publicado: (2019)

Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program
por: Rowe, Christopher L., et al.
Publicado: (2022)

Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic
por: Wang, Linda, et al.
Publicado: (2021)

Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage
por: Barsky, Benjamin A., et al.
Publicado: (2022)

“Sometimes you have to take the person and show them how”: adapting behavioral activation for peer recovery specialist-delivery to improve methadone treatment retention
por: Kleinman, Mary B., et al.
Publicado: (2023)

Federally Qualified Health Centers Can Expand Rural Access to Buprenorphine for Opioid Use Disorder in Arizona
por: Brady, Benjamin R, et al.
Publicado: (2021)

Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment
por: Belcher, Annabelle M, et al.
Publicado: (2019)

Low-barrier buprenorphine during the COVID-19 pandemic: A rapid transition to on-demand telemedicine with wide-ranging effects
por: Buchheit, Bradley M., et al.
Publicado: (2021)

Pattern of buprenorphine abuse among opioid abusers in Nepal
por: Aich, Tapas Kumar, et al.
Publicado: (2010)

Comparison of the Efficacy of Buprenorphine and Clonidine in Detoxification of Opioid-Dependents
por: Ziaaddini, Hassan, et al.
Publicado: (2012)

Sleep problems in opioid dependent patients maintained on buprenorphine
por: Tripathi, R., et al.
Publicado: (2021)

Personalized Care in Opioid Use Disorder maintained on Buprenorphine
por: Elarabi, H., et al.
Publicado: (2022)

Inpatient Buprenorphine Induction for Opioid Use Disorder in Pregnancy
por: Tavakoli, Amin, et al.
Publicado: (2023)

A urinalysis-based study of buprenorphine and non-prescription opioid use among patients on buprenorphine maintenance
por: Balhara, Yatan Pal Singh, et al.
Publicado: (2012)

Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees
por: Wen, Hefei, et al.
Publicado: (2018)

Factors in rural community buprenorphine dispensing
por: Major, Erin G., et al.
Publicado: (2022)

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
por: Flam-Ross, Juliet M., et al.
Publicado: (2023)

Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic
por: Mattocks, Kristin M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a70f470rgqeid4fb2limendk43